The FDA has modified the Emergency Use Authorizations (EUAs) for Pfizer-BioNTech COVID-19 vaccine and Moderna COVID-19 vaccine to allow for administration of a third dose of an mRNA COVID-19 vaccine after an initial two-dose primary mRNA COVID-19 vaccine series for certain immunocompromised people.
Topics Related to Bulletins
Recommendations for Non-Emergency Medical Transportation (NEMT) Vendors and Drivers
Additional clarification about Nurse Practitioner credentialing requirements
Claims may be submitted to NCTracks for all IFSP services for dates of service starting on July 1, 2021.
Coverage season will begin Aug. 15, 2021
All responses have been received and are available.
NC Medicaid advanced 54 providers to the site review stage.
Not required for medications administered at the provider’s office or outpatient hospital clinic settings and billed as part of the professional claim (Physician Administered Drug Program).
The extension granted through the hardship process is now matched by the extension granted through new legislation.
Providers and pharmacies should always use NCTracks to confirm eligibility.